Evaluation of liver function before and during therapy

References

[1] Kulik L.Epidemiology and management of hepatocellular carcinoma.Gastroenterology2019;156:477-91.e1 PMCID:PMC6340716

[2] Yang JD,Gores GJ.A global view of hepatocellular carcinoma: trends, risk, prevention and management.Nat Rev Gastroenterol Hepatol2019;16:589-604 PMCID:PMC6813818

[3] Yang JD,Cvinar JL.Diabetes mellitus heightens the risk of hepatocellular carcinoma except in patients with hepatitis C cirrhosis.Am J Gastroenterol2016;111:1573-80 PMCID:PMC6040826

[4] Younossi ZM,Blissett R.The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.Hepatology2016;64:1577-86

[5] Chayanupatkul M,Mittal S.Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.J Hepatol2017;66:355-362

[6] Couri T.Goals and targets for personalized therapy for HCC.Hepatol Int2019;13:125-37

[7] Serper M,Mehta R.Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality.Gastroenterology2017;152:1954-64 PMCID:PMC5664153

[8] Heimbach JK.Overview of the updated AASLD guidelines for the management of HCC.Gastroenterol Hepatol2017;13:751-3 PMCID:PMC5763563

[9] Schneider PD.Preoperative assessment of liver function.Surg Clin North Am2004;84:355-73

[10] Farges O,Flejou JF.Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal.Ann Surg1999;229:210-5 PMCID:PMC1191633

[11] Stockmann M,Malinowski M.The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery.HPB (Oxford)2010;12:139-46 PMCID:PMC2826673

[12] Buechter M,Baba HA.Liver maximum capacity: a novel test to accurately diagnose different stages of liver fibrosis.Digestion2019;100:45-54

[13] Buechter M,Gerken G.Enzymatic liver function measured by LiMAx - a reliable diagnostic and prognostic tool in chronic liver disease.Sci Rep2019;9:13577 PMCID:PMC6753134

[14] Anger F,Löb S.Preoperative liver function guiding HCC resection in normal and cirrhotic liver.Visc Med2021;37:94-101 PMCID:PMC8077495

[15] Blüthner E,Shrestha R.The predictive value of future liver remnant function after liver resection for HCC in noncirrhotic and cirrhotic patients.HPB (Oxford)2019;21:912-22

[16] Stockmann M,Fahrner R.Randomized clinical trial comparing liver resection with and without perioperative assessment of liver function.BJS Open2018;2:301-9 PMCID:PMC6156169

[17] Stockmann M,Riecke B.Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity.Ann Surg2009;250:119-25

[18] Barzakova ES,Zimmermann M.Monitoring liver function of patients undergoing transarterial chemoembolization (TACE) by a 13C breath test (LiMAx).Cardiovasc Intervent Radiol2019;42:1702-8

[19] Reichert MC,Schulz A.Volume-function analysis (LiMAx Test) in patients with HCC and cirrhosis undergoing TACE-A feasibility study.Dig Dis Sci2020;